AU2006217543A1 - Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof - Google Patents

Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof Download PDF

Info

Publication number
AU2006217543A1
AU2006217543A1 AU2006217543A AU2006217543A AU2006217543A1 AU 2006217543 A1 AU2006217543 A1 AU 2006217543A1 AU 2006217543 A AU2006217543 A AU 2006217543A AU 2006217543 A AU2006217543 A AU 2006217543A AU 2006217543 A1 AU2006217543 A1 AU 2006217543A1
Authority
AU
Australia
Prior art keywords
slc6a1
autism
gene
alteration
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006217543A
Other languages
English (en)
Inventor
Anne Philippi
Elke Roschmann
Francis Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntegraGen SA
Original Assignee
IntegraGen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntegraGen SA filed Critical IntegraGen SA
Publication of AU2006217543A1 publication Critical patent/AU2006217543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2006217543A 2005-02-28 2006-02-27 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof Abandoned AU2006217543A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65637405P 2005-02-28 2005-02-28
US60/656,374 2005-02-28
PCT/IB2006/001100 WO2006090288A2 (en) 2005-02-28 2006-02-27 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof

Publications (1)

Publication Number Publication Date
AU2006217543A1 true AU2006217543A1 (en) 2006-08-31

Family

ID=36607270

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006217543A Abandoned AU2006217543A1 (en) 2005-02-28 2006-02-27 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof

Country Status (7)

Country Link
US (1) US20080213765A1 (https=)
EP (1) EP1859060A2 (https=)
JP (1) JP2008532499A (https=)
AU (1) AU2006217543A1 (https=)
CA (1) CA2599327A1 (https=)
IL (1) IL184843A0 (https=)
WO (1) WO2006090288A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101935673B (zh) * 2009-07-03 2013-08-21 中国科学院上海生命科学研究院 用于抑制小鼠γ-氨基丁酸转运蛋白亚型1的siRNA

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4055174A4 (en) 2019-11-08 2024-01-03 The Board Of Regents Of The University Of Texas System TRANSGENIC CASSETTES, AAV VECTORS AND AAV VECTORS FOR EXPRESSING HUMAN CODON-OPTIMIZED SLCA1
WO2021113773A2 (en) * 2019-12-04 2021-06-10 Pai Athma A Identifying non-productive splice sites
IL301255A (en) * 2020-10-09 2023-05-01 UCB Biopharma SRL Nucleic acid structures, viral vectors and viral particles
CA3207224A1 (en) * 2021-02-02 2022-08-11 Bryan GORE Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes
WO2023022269A1 (ko) * 2021-08-20 2023-02-23 단국대학교 천안캠퍼스 산학협력단 주의력결핍 과잉행동장애의 예방 또는 치료용 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911130A1 (de) * 1999-03-12 2000-09-21 Hager Joerg Verfahren zur Identifikation chromosomaler Regionen und Gene
EP1554403A1 (en) * 2002-10-10 2005-07-20 K.U. Leuven Research and Development Autism gene

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101935673B (zh) * 2009-07-03 2013-08-21 中国科学院上海生命科学研究院 用于抑制小鼠γ-氨基丁酸转运蛋白亚型1的siRNA

Also Published As

Publication number Publication date
EP1859060A2 (en) 2007-11-28
US20080213765A1 (en) 2008-09-04
IL184843A0 (en) 2007-12-03
WO2006090288A2 (en) 2006-08-31
WO2006090288A3 (en) 2006-11-02
JP2008532499A (ja) 2008-08-21
CA2599327A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
US20100240539A1 (en) Human Autism Susceptibility Gene Encoding PRKCB1 and Uses Thereof
EP1656458B1 (en) Human autism susceptibility gene and uses thereof
AU2005258838B2 (en) Human autism predisposition gene encoding a transcription factor and uses thereof
AU2006215385B2 (en) Uses of human autism susceptibility gene encoding a kinase
US20080213765A1 (en) Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof
AU2006225995B2 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
WO2006003526A2 (en) Human autism susceptibility gene encoding otoa and uses thereof
AU2005254806B2 (en) Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof
US20090208482A1 (en) Human obesity susceptibility gene encoding a member of the neurexin family and uses thereof
US20080286765A1 (en) Human Obesity Susceptibility Gene Encoding a Taste Receptor and Uses Thereof

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period